REGENERATIVE EPITHELIAL SUSPENSION
DEAD

Serial Number

79180907

Owner

Avita Medical Ltd.

Filing Date

Oct 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

REGENERATIVE EPITHELIAL SUSPENSION Trademark

Serial Number: 79180907

REGENERATIVE EPITHELIAL SUSPENSION is a trademark filed by Avita Medical Ltd. on October 8, 2015. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Avita Medical Ltd. (8 trademarks)

Level 9, The Quadrant
Perth 6000 , AU

Entity Type: 03

AVITA Medical Americas, LLC

28159 Avenue Stanford
Valencia, CA 91355

Entity Type: 16

Trademark Details

Filing Date

October 8, 2015

Registration Date

Not Registered

Goods & Services

Non-medicated cosmetic skin regeneration products for the aesthetic treatment of skin burns, wounds, skin imperfections, and skin damages in the nature of liquids or creams for cosmetic purposes; non-medicated cosmetic preparations for skin care featuring enzymatically dissociated suspensions of epithelial cells and optionally additional factors that promote cell growth, cell reproduction, and cellular differentiation

Biological and chemical products for use in regenerative medicine for medical and/or aesthetic purposes, namely, biological epithelial tissue cells intended for subsequent implantation, epithelial grafts, biological preparations for the treatment of epithelial burns, wounds, and imperfections, chemical reagents for medical purposes, chemical preparations for medical purposes, namely, for treating epithelial burns, wounds, and imperfections; pharmaceutical and medical preparations for the treatment of epithelial burns, wounds, imperfections and other damages; medicaments to assist with the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; bio-compatible medicated epithelial preparations for treatment of epithelial imperfections, damages, diseases, and wounds, containing biomaterials, namely, enzymatically dissociated suspensions of epithelial cells and optionally additional factors for promoting cell growth, reproduction and/or differentiation; biological tissue cells, namely, reconstituted human epithelial tissues and cells for medical, clinical and/or aesthetic use

Filing History

DEATH OF INTERNATIONAL REGISTRATION
May 7, 2026 DETH
CHANGE OF OWNER RECEIVED FROM IB
Oct 4, 2024 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Aug 23, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 27, 2018 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2018 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 6, 2018 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 8, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 21, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 21, 2017 OPNR
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Mar 6, 2017 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Mar 6, 2017 ABN0
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 28, 2017 ERFR
FINAL REFUSAL MAILED
Aug 29, 2016 CNFR
FINAL REFUSAL WRITTEN
Aug 27, 2016 CNFR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 18, 2016 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2016 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 5, 2016 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2016 RFCR
NON-FINAL ACTION WRITTEN
Feb 3, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 2, 2016 MAFR
ASSIGNED TO EXAMINER
Jan 30, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 21, 2016 REPR